We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
+15.69%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$95.2M
AUM Growth
-$15.8M
(-14%)
Cap. Flow
-$23.2M
Cap. Flow
% of AUM
-24.35%
Top 10 Holdings %
Top 10 Hldgs %
20.01%
Holding
124
New
37
Increased
15
Reduced
36
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Healthcare Services Group
HCSG
|
+$1.51M |
| 2 |
Tyler Technologies
TYL
|
+$1.49M |
| 3 |
Steris
STE
|
+$1.44M |
| 4 |
Pacira BioSciences
PCRX
|
+$1.36M |
| 5 |
Commault Systems
CVLT
|
+$1.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$1.98M |
| 2 |
Axos Financial
AX
|
+$1.83M |
| 3 |
RDUS
Radius Health, Inc.
RDUS
|
+$1.75M |
| 4 |
Molina Healthcare
MOH
|
+$1.65M |
| 5 |
PGTI
PGT, Inc.
PGTI
|
+$1.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.67% |
| 2 | Healthcare | 25.31% |
| 3 | Consumer Discretionary | 15.48% |
| 4 | Industrials | 11.43% |
| 5 | Financials | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZLTQ
76
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $502K | 0.53% |
17,592
-30,915
| -64% | -$976K |
|
77
Fabrinet
FN
$16.2B
| $499K | 0.52% |
+20,966
| New | +$468K |
|
78
Matador Resources
MTDR
$6.13B
| $495K | 0.52% |
+25,048
| New | +$611K |
|
79
Ultragenyx Pharmaceutical
RARE
$2.46B
| $492K | 0.52% |
+4,385
| New | +$438K |
|
|
SSNI
80
DELISTED
Silver Spring Networks, Inc.
SSNI
| $477K | 0.5% |
+33,129
| New | +$463K |
|
81
Malibu Boats
MBUU
$545M
| $473K | 0.5% |
28,877
-4,723
| -14% | -$71.1K |
|
82
Paylocity
PCTY
$7.5B
| $456K | 0.48% |
+11,253
| New | +$432K |
|
|
ISEE
83
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $417K | 0.44% |
+5,310
| New | +$307K |
|
84
Glaukos
GKOS
$10.1B
| $307K | 0.32% |
12,425
-8,472
| -41% | -$194K |
|
|
ONDK
85
DELISTED
On Deck Capital, Inc.
ONDK
| $264K | 0.28% |
+25,622
| New | +$257K |
|
86
Vera Bradley
VRA
$99.5M
| $240K | 0.25% |
+15,215
| New | +$200K |
|
|
STMP
87
DELISTED
Stamps.com, Inc.
STMP
| $238K | 0.25% |
+2,175
| New | +$199K |
|
88
Ligand Pharmaceuticals
LGND
$5.76B
| $234K | 0.25% |
+3,454
| New | +$213K |
|
|
AVGR
89
DELISTED
Avinger, Inc. Common Stock
AVGR
| – | – |
0
| – | – |
|
|
AMED
90
DELISTED
Amedisys
AMED
| – | – |
-14,160
| Closed | -$538K |
|
91
AtriCure
ATRC
$1.99B
| – | – |
-70,367
| Closed | -$1.54M |
|
|
92
Axos Financial
AX
$5.88B
| – | – |
-56,808
| Closed | -$1.83M |
|
93
Builders FirstSource
BLDR
$7.72B
| – | – |
-89,935
| Closed | -$1.14M |
|
94
Covenant Logistics
CVLG
$883M
| – | – |
-142,550
| Closed | -$1.28M |
|
|
GES
95
DELISTED
Guess Inc
GES
| – | – |
-62,835
| Closed | -$1.34M |
|
96
G-III Apparel Group
GIII
$1.53B
| – | – |
-16,058
| Closed | -$990K |
|
97
MiMedx Group
MDXG
$637M
| – | – |
-104,204
| Closed | -$1.01M |
|
98
Marcus & Millichap
MMI
$1.16B
| – | – |
-26,095
| Closed | -$1.2M |
|
|
99
Molina Healthcare
MOH
$10.2B
| – | – |
-23,941
| Closed | -$1.65M |
|
100
Repligen
RGEN
$8.22B
| – | – |
-17,977
| Closed | -$501K |
|
Similar funds
GF
PIM
EH
TPWA
DL
STT
VC
CF
Lisanti Capital Growth's Q4 2015 Portfolio in Review
As of Q4 2015, Lisanti Capital Growth held 124 positions worth $95.2M, down 14% from $111M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Lisanti Capital Growth withdrew a net $23.2M in Q4 2015, closing 35 positions and reducing 36 holdings. Its most notable exit was Abiomed Inc, an estimated $1.98M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Lisanti Capital Growth opened a new position in Healthcare Services Group worth $1.45M.
- Lisanti Capital Growth's largest Q4 2015 buy was Healthcare Services Group: 41,616 shares worth $1.45M.
- Lisanti Capital Growth added most to Opus Bank Common Stock in Q4 2015, an estimated $853K increase.
- Lisanti Capital Growth's biggest Q4 2015 reduction was LogMein, Inc., cutting an estimated $1.62M.
- Lisanti Capital Growth fully exited Abiomed Inc in Q4 2015, selling an estimated $1.98M.
- Lisanti Capital Growth's ten largest holdings make up 20% of its $95.2M portfolio in Q4 2015.
- Lisanti Capital Growth opened 37 new positions and closed 35 in Q4 2015.
- Lisanti Capital Growth's portfolio value fell 14% quarter-over-quarter to $95.2M.
Based on Lisanti Capital Growth's 13F filing for Q4 2015, filed 5 Feb 2016.